Search results
Author(s):
Ghanshyam Shantha
,
Frank Pelosi
,
Fred Morady
Added:
3 years ago
Prevalence of AF and Obstructive Sleep Apnoea
Nonvalvular AF is the most common sustained arrhythmia, affecting nearly 3 million adult Americans.1–4 By 2050, nearly 12–15 million adults in the US will have AF.1 The global prevalence of obstructive sleep apnoea (OSA) is also increasing. OSA is the most common form of sleep-disordered breathing, affecting 10–15% of the general population (6–9% in…
View more
Author(s):
Ling Zhang
,
Yuemei Hou
,
Sunny S Po
Added:
3 years ago
Atrial fibrillation(AF) is the most frequently encountered arrhythmia in clinical practice and has become an emerging epidemic. AF is associated with increased cardiovascular mortality and morbidy such as stroke.1–3 Over 2.3 million people in the US are affected by AF: it is estimated that AF will affect more than 15 million Americans by 2050.3 The traditional risk factors implicated in the…
View more
Mapping AF Structural Substrates
Author(s):
Ahmed M Al-Kaisey
,
Ramanathan Parameswaran
,
Jonathan M Kalman
Added:
3 years ago
Article
Author(s):
Suneet Mittal
,
David Golombeck
,
Jacqueline Pimienta
Added:
2 years ago
Author(s):
Klaus-Jürgen Gutleben
,
Henrik Fox
,
Thomas Bitter
,
et al
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Author(s):
George D Katritsis
,
Demosthenes G Katritsis
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Author(s):
Dominik Linz
,
Sander Verheule
,
Aaron Isaacs
,
et al
Added:
2 years ago
Author(s):
Nicolas Johner
,
Mehdi Namdar
,
Dipen Shah
Added:
3 years ago
Catheter ablation (CA) is a widely used first-line treatment for AF. Randomised controlled trials (RCTs) have shown its superiority to pharmacological treatment in terms of symptom control, rhythm control and mortality in selected patients; observational studies have also suggested a decreased risk of stroke.1,2 Pulmonary vein isolation (PVI) is the standard endpoint, but studies have reported…
View more
Obesity and Atrial Fibrillation
Author(s):
Vishal Vyas
,
Pier D Lambiase
Added:
3 years ago
Article